$5.8MSeries A, 3 March 2026
Series A1 equity plus EIC award to fund first-in-human studies and production readiness.
- Amount
- $5.8M
- Stage
- Series A
- Announced
- 3 March 2026
- Lead
- bmp Ventures
- Other investors
- IBG, GETEC Family Office, High-Tech Gründerfonds
- Use of funds
- Series A1 equity plus EIC award to fund first-in-human studies and production readiness.
- Checked
- Amount and date matched across 2 press sources
- Sources
- €7.5M for RAYDIAX to trial therapy CT scanner techfundingnews.com
€7.5M for RAYDIAX to trial therapy CT scanner pulse2.com